|
|
|
|
| RLN401b | PD-L1检测的非小细胞肺癌组织芯片，附病理分级、TNM、临床分期和PD-L1(Sp263)结果，40例/40点，替代LC401a | | | 点 数 | 40 | 例 数 | 40 | | 行 数 | 5 | 列 数 | 8 | | 点直径(mm) | 1.5 | 厚度(µm) | 5.0 | | 组织阵列类型 | 石蜡包埋 | 种 属 | 人类 | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
|
Malignant (IB) Malignant (IIA) Malignant (IIB) Malignant (IIIA) Malignant (IIIB) Malignant (IIIC) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | isBackUp |
| A1 | 1 | 63 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIA | Malignant | N |
| A2 | 2 | 54 | M | Lung | Squamous cell carcinoma | 2 | T2N2M0 | IIIA | Malignant | N |
| A3 | 3 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIA | Malignant | N |
| A4 | 4 | 65 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| A5 | 5 | 60 | M | Lung | Squamous cell carcinoma | 2 | T2N2M0 | IIIA | Malignant | N |
| A6 | 6 | 57 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| A7 | 7 | 51 | M | Lung | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| A8 | 8 | 61 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T3N2M0 | IIIB | Malignant | N |
| B1 | 9 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| B2 | 10 | 68 | M | Lung | Squamous cell carcinoma | 2 | T2bN0M0 | IIA | Malignant | N |
| B3 | 11 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| B4 | 12 | 64 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIA | Malignant | N |
| B5 | 13 | 64 | M | Lung | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant | N |
| B6 | 14 | 58 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| B7 | 15 | 56 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | N |
| B8 | 16 | 69 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | N |
| C1 | 17 | 70 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant | N |
| C2 | 18 | 58 | M | Lung | Squamous cell carcinoma | 3 | T2N1M0 | IIA | Malignant | N |
| C3 | 19 | 60 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| C4 | 20 | 52 | M | Lung | Squamous cell carcinoma | 3 | T3N2M0 | IIIB | Malignant | N |
| C5 | 21 | 54 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| C6 | 22 | 57 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| C7 | 23 | 36 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| C8 | 24 | 42 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| D1 | 25 | 65 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| D2 | 26 | 48 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| D3 | 27 | 52 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| D4 | 28 | 64 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| D5 | 29 | 58 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | N |
| D6 | 30 | 49 | M | Lung | Squamous cell carcinoma | 3 | T2N1M0 | IIA | Malignant | N |
| D7 | 31 | 50 | F | Lung | Squamous cell carcinoma | 3 | T3N3M0 | IIIC | Malignant | N |
| D8 | 32 | 57 | M | Lung | Squamous cell carcinoma | 3 | T3N0M0 | IIB | Malignant | N |
| E1 | 33 | 54 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | N |
| E2 | 34 | 64 | M | Lung | Squamous cell carcinoma | 3 | T2N2M0 | IIIA | Malignant | N |
| E3 | 35 | 62 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| E4 | 36 | 62 | F | Lung | Squamous cell carcinoma | * | T2N0M0 | IB | Malignant | N |
| E5 | 37 | 58 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | N |
| E6 | 38 | 43 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant | N |
| E7 | 39 | 70 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | N |
| E8 | 40 | 46 | M | Lung | Squamous cell carcinoma with necrosis | 3 | T3N1M0 | IIIA | Malignant | N | | Tissue Marker |
|
|
